We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+9.6%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$72.7B
AUM Growth
+$7.54B
(+12%)
Cap. Flow
-$3.34B
Cap. Flow
% of AUM
-4.6%
Top 10 Holdings %
Top 10 Hldgs %
23.55%
Holding
2,585
New
253
Increased
940
Reduced
728
Closed
298
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Crown Castle
CCI
|
+$536M |
| 2 |
Procter & Gamble
PG
|
+$358M |
| 3 |
CSX Corp
CSX
|
+$303M |
| 4 |
NVIDIA
NVDA
|
+$186M |
| 5 |
Eli Lilly
LLY
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetEase
NTES
|
+$370M |
| 2 |
American Electric Power
AEP
|
+$338M |
| 3 |
Alibaba
BABA
|
+$322M |
| 4 |
Prologis
PLD
|
+$307M |
| 5 |
HEICO Corp
HEI
|
+$287M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.03% |
| 2 | Financials | 13.75% |
| 3 | Industrials | 12.1% |
| 4 | Healthcare | 10.45% |
| 5 | Consumer Discretionary | 7.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SVM
1076
Silvercorp Metals
SVM
$2.39B
| $1.1M | ﹤0.01% |
+260,198
| New | +$1.01M |
|
1077
Vanguard FTSE All-World ex-US ETF
VEU
$67.9B
| $1.1M | ﹤0.01% |
16,316
+8,530
| +110% | +$540K |
|
1078
Conagra Brands
CAG
$7.15B
| $1.09M | ﹤0.01% |
53,475
+22,930
| +75% | +$537K |
|
1079
Charles River Laboratories
CRL
$12.5B
| $1.09M | ﹤0.01% |
7,198
+2,952
| +70% | +$394K |
|
1080
STAG Industrial
STAG
$7.1B
| $1.09M | ﹤0.01% |
30,006
+527
| +2% | +$18.2K |
|
1081
Phillips Edison & Co
PECO
$5.28B
| $1.08M | ﹤0.01% |
30,876
+314
| +1% | +$11.1K |
|
1082
Independent Bank
INDB
$4.02B
| $1.08M | ﹤0.01% |
17,128
+1,380
| +9% | +$83.9K |
|
1083
Third Coast Bancshares
TCBX
$731M
| $1.07M | ﹤0.01% |
32,890
-9,982
| -23% | -$304K |
|
1084
Ero Copper
ERO
$3.22B
| $1.07M | ﹤0.01% |
+63,724
| New | +$861K |
|
1085
Adecoagro
AGRO
$1.36B
| $1.07M | ﹤0.01% |
116,933
+116,882
| +229,180% | +$1.14M |
|
1086
PTC Therapeutics
PTCT
$5.87B
| $1.06M | ﹤0.01% |
21,826
-278
| -1% | -$13.2K |
|
|
BFS
1087
Saul Centers
BFS
$831M
| $1.06M | ﹤0.01% |
31,196
+2,487
| +9% | +$83.9K |
|
1088
COPT Defense Properties
CDP
$4.23B
| $1.06M | ﹤0.01% |
38,536
-7,319
| -16% | -$198K |
|
1089
Cerus
CERS
$470M
| $1.06M | ﹤0.01% |
749,964
+107,213
| +17% | +$143K |
|
1090
Oxford Industries
OXM
$564M
| $1.05M | ﹤0.01% |
26,031
+25,180
| +2,959% | +$1.27M |
|
|
PENG
1091
Penguin Solutions Inc
PENG
$2.92B
| $1.05M | ﹤0.01% |
52,934
+42,859
| +425% | +$775K |
|
1092
Elanco Animal Health
ELAN
$12B
| $1.04M | ﹤0.01% |
72,981
+65,656
| +896% | +$767K |
|
1093
MarketAxess Holdings
MKTX
$5.72B
| $1.04M | ﹤0.01% |
4,650
-1,048
| -18% | -$230K |
|
1094
Expedia Group
EXPE
$37.3B
| $1.04M | ﹤0.01% |
6,145
-75,402
| -92% | -$12.2M |
|
1095
VeriSign
VRSN
$26.5B
| $1.02M | ﹤0.01% |
3,540
-17,710
| -83% | -$4.8M |
|
1096
HealthStream
HSTM
$816M
| $1.02M | ﹤0.01% |
36,908
-2,784
| -7% | -$82.3K |
|
1097
Central Pacific Financial
CPF
$1.01B
| $1.02M | ﹤0.01% |
+36,380
| New | +$958K |
|
1098
Essent Group
ESNT
$6.02B
| $1.02M | ﹤0.01% |
16,789
+13,510
| +412% | +$779K |
|
1099
CDW
CDW
$18.1B
| $1.02M | ﹤0.01% |
5,695
-743
| -12% | -$126K |
|
1100
Arch Capital
ACGL
$33.9B
| $1.01M | ﹤0.01% |
11,154
-18,105
| -62% | -$1.67M |
|
Similar funds
QCM
Lazard Asset Management's Q2 2025 Portfolio in Review
As of Q2 2025, Lazard Asset Management held 2,585 positions worth $72.7B, up 12% from $65.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Lazard Asset Management withdrew a net $3.34B in Q2 2025, closing 298 positions and reducing 728 holdings. Its most notable exit was Eastman Chemical, an estimated $13.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Financials and Industrials.
Against the trend, Lazard Asset Management opened a new position in Arcos Dorados Holdings worth $117M.
- Lazard Asset Management's largest Q2 2025 buy was Arcos Dorados Holdings: 14,873,278 shares worth $117M.
- Lazard Asset Management added most to Crown Castle in Q2 2025, an estimated $536M increase.
- Lazard Asset Management's biggest Q2 2025 reduction was NetEase, cutting an estimated $370M.
- Lazard Asset Management fully exited Eastman Chemical in Q2 2025, selling an estimated $13.1M.
- Lazard Asset Management's ten largest holdings make up 24% of its $72.7B portfolio in Q2 2025.
- Lazard Asset Management opened 253 new positions and closed 298 in Q2 2025.
- Lazard Asset Management's portfolio value rose 12% quarter-over-quarter to $72.7B.
Based on Lazard Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.